amubarvimab (BRII-196) - Brii Biosci
|
Evusheld (cilgavimab/tixagevimab) - AstraZeneca
|
bamlanivimab (LY-CoV555) - Eli Lilly, AbCellera, National Institute of Allergy and Infectious Diseases
|
romlusevimab (BRII-198) - Brii Biosci
|
Xevudy (sotrovimab) - GSK, National Institutes of Health, Vir Biotech, National Institute of Allergy and Infectious Diseases
|
PF-07304814 - Pfizer
|
remdesivir - Generic mfg.
|
ensovibep (MP0420) - AGC Biologics, Molecular Partners, Novartis
|